1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (10830)
  2. Meeting Abstract (9435)
  3. Review (542)
  4. Book Section (410)
  5. Editorial (324)
  6. Guidelines (154)
  7. Correspondence (115)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (53)
  11. Book Whole (27)
Groups
  1. Solid Tumor Oncology Division (22056)
  2. Department of Medicine (22034)
  3. GSK Faculty (5880)
  4. Genitourinary Oncology Service (5608)
  5. Survivorship Research (5183)
  6. Gastrointestinal Oncology Service (4640)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (869)
  6. Leonard Saltz (790)

More People

Years
  1. 2025 (445)
  2. 2024 (1382)
  3. 2023 (1380)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1535)

More Years

Publications
  1. Journal of Clinical Oncology (5227)
  2. Annals of Oncology (1294)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (768)
  5. Journal of Thoracic Oncology (530)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5507)
  2. Elsevier Inc. (2651)
  3. American Association for Cancer Research (2316)
  4. Oxford University Press (1810)
  5. Nature Publishing Group (1026)
  6. Springer (975)

More Publishers

Results (22056)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of buparlisib (BKM120) with bevacizumab (BEV) in patients (pts) with metastatic renal cell carcinoma (mRCC) progressing on prior vascular endothelial growth factor (VEGF) therapies
    Meeting Abstract

    McKay, R. R.; Werner, L.; Harshman, L. C.; Bellmunt, J.; Sweeney, C.; Rosenberg, J. E.; VanAllen, E.; Walsh, M. K.; Vaishampayan, U. N.; McDermott, D. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Analysis of real world treatment compliance in a cohort of 2,395 patients with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Margolis, J.; Princic, N.; Doan, J.; Lenhart, G.; Motzer, R.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Low objective response and high toxicity to single-agent mitotane in patients with metastatic adrenocortical carcinoma (ACC): A 25 year experience at MSKCC
    Meeting Abstract

    Lung, B. Y.; Valentino, E.; Gerst, S. R.; Untch, B. R.; Katz, S.; Strong, V. E.; Raj, N. P.; Olino, K.; Saltz, L.; Reidy, D. L.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • A phase I trial of binimetinib in combination with gemcitabine (G) and cisplatin (C) patients (pts) with untreated advanced biliary cancer (ABC)
    Meeting Abstract

    Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Salehi, E.; Hollywood, E.; Bradley, M.; Sophos, N. A.; Ly, M.; Capanu, M.; Gerst, S. R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Early CTC decline as a biomarker of response to treatment in castration-resistant prostate cancer (CRPC): Analysis of the COU-AA-301 and IMMC38 trials
    Meeting Abstract

    Lorente, D.; Olmos, D.; Mateo, J.; Bianchini, D.; Seed, G.; Flohr, P.; Crespo, M.; Figueiredo, I.; Miranda, S.; Baeten, K.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of bortezomib in KRAS G12D mutant lung cancers
    Meeting Abstract

    Litvak, A. M.; Drilon, A. E.; Rekhtman, N.; Pietanza, M. C.; Chaft, J. E.; Woo, K.; Paik, P. K.; Kris, M. G.; Riely, G. J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Association between geographic access to cancer care and receipt of chemotherapy: Geographic distribution of oncologists and travel distance
    Meeting Abstract

    Lin, C. C.; Bruinooge, S. S.; Kirkwood, K. M.; Olsen, C. C.; Bajorin, D. F.; Jemal, A.; Giordano, S. H.; Goldstein, M.; Guadagnolo, B. A.; Kosty, M. P.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Outcomes of stage IA polyp-limited vs endometrium-limited epithelial high grade endometrial carcinoma (EMC)
    Meeting Abstract

    Liang, L.; Perez, A. R.; Cangemi, N. A.; Zhou, Q.; Iasonos, A.; Alektiar, K. M.; Abu Rustum, N.; Makker, V.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Defining the spectrum and "overlap" of HER2 aberrations in lung cancers: Associations of HER2 protein overexpression, HER2 amplification, and HER2 mutation
    Meeting Abstract

    Li, B. T.; Ross, D. S.; Chaft, J. E.; Hsu, M.; Kako, S.; Aisner, D. L.; Kris, M. G.; Varella-Garcia, M.; Arcila, M. E.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Novel chromosome copy number changes to predict clinical response to sunitinib in patients with advanced renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; Motzer, R.; Hoetker, A.; Akin, O.; Molina, A. M.; Gold, T. M.; Patil, S.; Gowrishankar, B.; Houldsworth, J.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save